Skip to main content
Journal of Assisted Reproduction and Genetics logoLink to Journal of Assisted Reproduction and Genetics
. 2001 Feb;18(2):87–90. doi: 10.1023/A:1026530624575

CLINICAL ASSISTED REPRODUCTION: Human Chorionic Gonadotropin-to-Oocyte Collection Interval in a Superovulation IVF Program. A Prospective Study

G Nargund 1, F Reid 2, J Parsons 3
PMCID: PMC3455552  PMID: 11285986

Abstract

Purpose: The aim of this study was to investigate whether the hCG–oocyte collection interval has any influence on the oocyte recovery rate, fertilization rate, and outcome of IVF-ET cycles.

Methods: Five hundred thirty-three consecutive patients undergoing their first IVF-ET treatment cycle at King's Assisted Conception Unit between 1993 and 1995 were included in this study.

Results: There was no significant difference in the oocyte recovery rates, fertilization rates, or outcome of IVF-ET treatment among the hCG–oocyte collection intervals examined (33–41 hr). None of the 533 women studied had ovulated before oocyte collection.

Conclusions: The results do not suggest a trend toward increased ovulation more than 36 hr after hCG administration.

Keywords: Human chorionic gonadotropin, interval, IVF, oocyte collection, pituitary downregulation

Full Text

The Full Text of this article is available as a PDF (52.2 KB).

REFERENCES

  • 1.Loumaye E. The control of endogenous secretion of LH by Gn RH agonists during ovarian hyperstimulation for IVF and ET. Hum Reprod. 1990;5:357–376. doi: 10.1093/oxfordjournals.humrep.a137105. [DOI] [PubMed] [Google Scholar]
  • 2.Tan SL, Campbell S, Balen A, et al. A prospective randomised study of the optimum timing of human chorionic gonadotropin administration after pituitary desensitisation in in-vitro fertilisation. Fertil Steril. 1992;57:1259–1261. doi: 10.1016/s0015-0282(16)55084-5. [DOI] [PubMed] [Google Scholar]
  • 3.Mansour RT, Aboulghar MA, Serour GI. Study of the optimum time for human chorionic gonadotropin-ovum pickup interval in in vitro fertilisation. Assist Reprod Genet. 1994;11:478–481. doi: 10.1007/BF02215712. [DOI] [PubMed] [Google Scholar]
  • 4.Nader S, Berkowitz A. Study of the pharmacokinetics of human chorionic gonadotropin and its relation to ovulation. In Vitro Fert Embryo Transfer. 1990;7:114–117. doi: 10.1007/BF01135585. [DOI] [PubMed] [Google Scholar]
  • 5.Edwards RG, Steptoe PC. Induction of follicular growth, ovulation and luteinisation in the human ovary. J Reprod Fertil. 1975;22(Suppl):121–153. [PubMed] [Google Scholar]
  • 6.Testart J, Frydman R. Minimum time lapse between luteinising hormone surge or human chorionic gonadotropin administration and follicular rupture. Fertil Steril. 1982;37:50–53. doi: 10.1016/s0015-0282(16)45976-5. [DOI] [PubMed] [Google Scholar]
  • 7.Jagiello G, Karniki J, Ryan RJ. Superovulation with pituitary gonadotropin methods for obtaining meiotic metaphase figures in human ova. Lancet. 1968;1:178–180. [Google Scholar]

Articles from Journal of Assisted Reproduction and Genetics are provided here courtesy of Springer Science+Business Media, LLC

RESOURCES